Laura A Garvican-Lewis1,2, Victor L Vuong2, Andrew D Govus3, Peter Peeling4,5, Grace Jung6, Elizabeta Nemeth6, David Hughes2, Greg Lovell2, Daniel Eichner7, Christopher J Gore2. 1. Mary Mackillop Institute for Health Research, Australian Catholic University, Melbourne, AUSTRALIA. 2. Australian Institute of Sport, Canberra, AUSTRALIA. 3. Swedish Winter Sports Research Centre, Mid Sweden University, Östersund, SWEDEN. 4. Western Australian Institute of Sport, Perth, AUSTRALIA. 5. School of Human Sciences (Exercise and Sports Science), University of Western Australia, Perth, AUSTRALIA. 6. Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA. 7. Sports Medicine Research and Testing Laboratory, Salt Lake City, UT.
Abstract
PURPOSE: Iron is integral for erythropoietic adaptation to hypoxia, yet the importance of supplementary iron compared with existing stores is poorly understood. The aim of the present study was to compare the magnitude of the hemoglobin mass (Hbmass) in response to altitude in athletes with intravenous (IV), oral, orplacebo iron supplementation. METHODS:Thirty-four, nonanemic, endurance-trained athletes completed 3 wk of simulated altitude (3000 m, 14 h·d), receiving two to three bolus iron injections (ferric carboxymaltose), daily oral iron supplementation (ferrous sulfate), or a placebo, commencing 2 wk before and throughout altitude exposure. Hbmass and markers of iron regulation were assessed at baseline (day -14), immediately before (day 0), weekly during (days 8 and 15), and immediately, 1, 3, and 6 wk after (days 22, 28, 42, and 63) the completion of altitude exposure. RESULTS: Hbmass significantly increased after altitude exposure in athletes with IV (mean % [90% confidence interval (CI)], 3.7% [2.8-4.7]) and oral (3.2% [2.2-4.2]) supplementation and remained elevated at 7 d postaltitude in oral (2.9% [1.5-4.3]) and 21 d after in IV (3.0% [1.5-4.6]) supplementation. Hbmass was not significantly higher than baseline at any time point in placebo. CONCLUSIONS:Iron supplementation appears necessary for optimal erythropoietic adaptation to altitude exposure. IV iron supplementation during 3 wk of simulated live high-train low altitude training offered no additional benefit in terms of the magnitude of the erythropoietic response for nonanemic endurance athletes compared with oral supplementation.
RCT Entities:
PURPOSE:Iron is integral for erythropoietic adaptation to hypoxia, yet the importance of supplementary iron compared with existing stores is poorly understood. The aim of the present study was to compare the magnitude of the hemoglobin mass (Hbmass) in response to altitude in athletes with intravenous (IV), oral, or placebo iron supplementation. METHODS: Thirty-four, nonanemic, endurance-trained athletes completed 3 wk of simulated altitude (3000 m, 14 h·d), receiving two to three bolus iron injections (ferric carboxymaltose), daily oral iron supplementation (ferrous sulfate), or a placebo, commencing 2 wk before and throughout altitude exposure. Hbmass and markers of iron regulation were assessed at baseline (day -14), immediately before (day 0), weekly during (days 8 and 15), and immediately, 1, 3, and 6 wk after (days 22, 28, 42, and 63) the completion of altitude exposure. RESULTS:Hbmass significantly increased after altitude exposure in athletes with IV (mean % [90% confidence interval (CI)], 3.7% [2.8-4.7]) and oral (3.2% [2.2-4.2]) supplementation and remained elevated at 7 d postaltitude in oral (2.9% [1.5-4.3]) and 21 d after in IV (3.0% [1.5-4.6]) supplementation. Hbmass was not significantly higher than baseline at any time point in placebo. CONCLUSIONS:Iron supplementation appears necessary for optimal erythropoietic adaptation to altitude exposure. IV iron supplementation during 3 wk of simulated live high-train low altitude training offered no additional benefit in terms of the magnitude of the erythropoietic response for nonanemic endurance athletes compared with oral supplementation.
Authors: Marc Sim; Laura A Garvican-Lewis; Gregory R Cox; Andrew Govus; Alannah K A McKay; Trent Stellingwerff; Peter Peeling Journal: Eur J Appl Physiol Date: 2019-05-04 Impact factor: 3.078
Authors: Santiago Sanz-Quinto; Manuel Moya-Ramón; Gabriel Brizuela; Ian Rice; Tomás Urbán; Raúl López-Grueso Journal: J Int Soc Sports Nutr Date: 2019-11-10 Impact factor: 5.150
Authors: Trent Stellingwerff; Peter Peeling; Laura A Garvican-Lewis; Rebecca Hall; Anu E Koivisto; Ida A Heikura; Louise M Burke Journal: Sports Med Date: 2019-12 Impact factor: 11.136
Authors: Marcus P Hannon; Joelle Leonie Flueck; Vincent Gremeaux; Nicolas Place; Bengt Kayser; Chris Donnelly Journal: Front Sports Act Living Date: 2021-01-27
Authors: Anu E Koivisto-Mørk; Ingvild Paur; Gøran Paulsen; Ina Garthe; Truls Raastad; Nasser E Bastani; Rune Blomhoff; Siv K Bøhn Journal: Front Sports Act Living Date: 2020-08-26